Both partners’ will leverage their nuclear research facilities and expertise to develop new health interventions
Month: April 2024
NSCLC is the most common type of lung cancer and is responsible for up to 85% of all […]
A new study reveals why some pancreatic and colorectal tumors resist targeted anti-Wnt drugs and suggests how to […]
A Cystic Fibrosis drug targeting the basic defect that causes the condition has been shown to be safe […]
A woman in her late 30s presented with golden brown lesions of both corneas during a routine ophthalmic […]
A drug approved to treat pulmonary arterial hypertension may be effective at managing hypertension and end-organ damage in […]
Over 75% of staff working in the NHS are women,1 and they often find themselves navigating sexism. Recent […]
RTIs account for around 60% of global antibiotic prescribing and are a key driver of AMR
Prostate cancer is responsible for around 12,000 deaths a year in the UK and is the second biggest […]
Findings show a newly created drug can prevent runaway inflammation while still allowing the immune system to handle […]